About This Program
Wegovy Pills at Soboba
Wegovy Pill is a once-daily oral semaglutide option for adults who want medical support for chronic weight loss without using a weekly injection. The FDA approved Wegovy tablets in December 2025 as an oral GLP-1 medicine for adults with obesity or adults with overweight who also have at least one weight-related medical condition.
At Soboba Medical Weight Loss, all programs are supervised by licensed physicians who review your health history, confirm candidacy, and guide your treatment from the first consultation through ongoing progress. Every program includes free physician visits, free nutrition counseling, and no startup fees.
How The Wegovy Pill Supports Weight Loss
GLP-1 medications work by helping regulate appetite signals, slowing stomach emptying, and improving control of hunger and fullness. Wegovy Pills contain semaglutide — the same active ingredient as the injectable form — delivered as a once-daily oral tablet.
Reduces appetite signals so patients feel less hungry throughout the day
Slows gastric emptying so meals produce longer-lasting fullness
Supports lower calorie intake without extreme dietary restriction
Works alongside physician guidance, nutrition counseling, and healthy lifestyle changes
How To Take The Wegovy Pill
Take the Wegovy Pill in the morning on an empty stomach with up to 4 ounces of water only — no other beverages. Wait at least 30 minutes before eating, drinking, or taking other oral medications. The tablet should be swallowed whole and never chewed, crushed, or split.
Monthly Supply & Instructions
Your Wegovy Pill supply will include 28 pills for the month. Take one pill per day unless your Soboba physician provides different instructions. Do not take more than prescribed.
Who May Be A Candidate?
You may be a candidate for the Wegovy Pill if you are an adult with obesity (BMI ≥ 30) or an adult who is overweight (BMI ≥ 27) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol — and you are seeking a medically supervised oral weight loss option.
Who Should Avoid the Wegovy Pill
The Wegovy Pill is contraindicated for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. The FDA label warns that acute pancreatitis has been observed in patients treated with GLP-1 receptor agonists, including Wegovy. Your Soboba physician will review your complete health history at your consultation.
The most common side effects associated with Wegovy include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, and dizziness. These symptoms often improve as your body adjusts. Medical supervision is important throughout your program.
Wegovy Pill vs. Wegovy Injection
Wegovy Pill
Wegovy Injection
All Soboba Programs Include
Frequently Asked Questions
What Is The Wegovy Pill?
The Wegovy Pill is an oral form of semaglutide used for medical weight management in adults with obesity or overweight with at least one weight-related health condition.
How Does The Wegovy Pill Help With Weight Loss?
The Wegovy Pill works by helping reduce appetite, increase feelings of fullness, and support lower calorie intake as part of a physician-supervised weight loss plan that includes healthier eating and physical activity.
Who Is A Good Candidate For The Wegovy Pill?
A good candidate may be an adult struggling with obesity or excess weight who wants a medically supervised weight loss option without weekly injections. Your Soboba physician will confirm candidacy at your free consultation.
How Do You Take The Wegovy Pill?
The Wegovy Pill is taken once daily in the morning on an empty stomach with up to 4 ounces of water only. Wait at least 30 minutes before eating, drinking other beverages, or taking other oral medications. The tablet should be swallowed whole.
How Long Does It Take To See Results?
Results vary by patient. In clinical data for Wegovy tablets, patients taking the tablet showed greater weight reduction than placebo at 64 weeks. Your Soboba physician will monitor your progress throughout your program.
Is The Wegovy Pill The Same As The Wegovy Injection?
Both contain semaglutide, but the pill and injection are taken differently and may have different dosing schedules. Your physician will help determine which option is best suited for your health history and goals.
What Are The Common Side Effects?
Common side effects may include nausea, vomiting, diarrhea, constipation, stomach discomfort, headache, fatigue, and dizziness. These often improve as your body adjusts. Your Soboba physician will monitor your response throughout treatment.
Who Should Not Take The Wegovy Pill?
The Wegovy Pill may not be appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your physician will review your full medical history at your free consultation.
Do I Still Need Diet And Exercise?
Yes. The Wegovy Pill works best as part of a complete medical weight loss plan that includes healthier eating, physical activity, and behavioral changes. Soboba provides free nutrition counseling with every program.
How Can I Start The Wegovy Pill At Soboba?
Call any Soboba Medical Weight Loss location in Orange County to schedule a free consultation. Your physician will review your health history and determine whether the Wegovy Pill is appropriate for you.
Ready to Start?
Same-week appointments available. Call any of our 3 Orange County locations — first consultation is free.
Why Choose Soboba
Start Your Wegovy Pill Program Today
Free doctor visits included. No startup fees. No contracts. Same-week appointments available at all 3 Orange County locations.
Call Now — Free ConsultationSame-week appointments available · No contracts · No startup fees
Individual results may vary. This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. All programs are supervised by licensed physicians. These statements have not been evaluated by the Food and Drug Administration.